Patents law

Intellectual property rights and assets have become a major contributor to market capitalization for different companies.

Patents, including pharmaceutical patents, enjoy extended protection for twenty years under the TRIPs Agreement.

This book provides the first comprehensive study of what cannot be patented and what should not be patentable in Europe.

In this thought-provoking analysis, the author takes three examples of emerging markets (Brazil, India, and Nigeria) and tells their stories of pharmaceutical patent law-making.

This book explores the question of whether software should be patented.

This book provides detailed instructions for reading and writing a patent.

This book explores the question of whether software should be patented.

This comprehensive book is the first of its kind to take scientists and engineers beyond simply getting a patent granted.

Although the law on infringement is relatively straightforward in relation to thecopying of literal and textual elements of software, it is the copying of non-literaland functional elements that poses complex and topical questions in the contextof intellectual property (IP) protection.

Patent Transactions in the Life Sciences is designed to provide guidance on the structure and detail of those agreements in the life sciences sector that are based on its most important assets - patents and know-how.

Global Patents: Limits of Transnational Enforcement explains why a "e;global patent"e; does not exist.

The classic guide to cashing in on your million-dollar idea Whether you've invented a great new product, or you have an idea for an app, an online business, or a reality show, How to License Your Million Dollar Idea delivers the information you need to snag a great licensing deal.

As individuals and companies realise the importance of their inventions, issues surrounding patent laws and practices are taking centre stage around the world.

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law.

This book proposes an approach to the patent-competition interface for developing countries.

Publishing continues to be a major industry worldwide, and this book is designed to assist the thousands of entities that regularly contract into a variety of agreements and need advice in drafting or negotiating the best terms for a deal, or otherwise employing or understanding specific terms used.

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law.

In the new 'knowledge-intensive economies' Intellectual assets increasingly play a key part on balance sheets.

Peter Drahos argues that patent offices serve multinational elites and undermine public rights under the patent social contract.

Intellectual property rights and assets have become a major contributor to market capitalization for different companies.

Creators and creative industries are struggling to navigate the digital age.

Patents for Chemicals, Pharmaceuticals and Biotechnology is the established and highly-acclaimed introduction to patent law and practice, guiding the reader through the legal and procedural complexities of the British, European, Japanese, and United States patent systems.

Survey of the theory, empirical evidence and public policy related to the role of patents in a global knowledge economy.

Sharing biological resources—critical for new medicines and vaccines—has declined as countries and scientists dispute rights over research.

This book explores the relationship between intellectual property law and competition law, proposing a harmonious equilibrium in the dynamic landscape of evolving technology.

This book provides an overview of developments in personalized medicine patenting and explores its normative implications to suggest policies to best regulate it.

What is the licensing framework of standard essential patents (SEPs) for connectivity standards such as 5G and Wi-Fi?

The story of the commercialization of biology by a pioneer in biotechnology patentingShortly after the emergence of genetic engineering in the 1970s, academic biologists were courted by venture capitalists and multinational companies.

Coalitions and Compliance examines how international changes can reconfigure domestic politics.

IP law has evolved from being a little pool to a big ocean.

This cutting-edge volume offers a theoretical and applied introduction to the emerging legal technology and informatics industry.

This edition is fully updated to reflect the Digital Economy Act 2010 and changes to consumer protection law at EU level including the Unfair Commercial Practices Directive.

Examines the right to parody as a natural right in both the free speech and the copyright contexts.

The classic guide to cashing in on your million-dollar idea Whether you've invented a great new product, or you have an idea for an app, an online business, or a reality show, How to License Your Million Dollar Idea delivers the information you need to snag a great licensing deal.

The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime.

Since the publication of the 2nd edition additional countries especially in Asia have become more prominent in industry.

Patent law is crucial to encourage technological innovation.

The rise of China's economy has led to a substantial increase in disputes involving intellectual property rights, including patents.

The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning.

Patents, including pharmaceutical patents, enjoy extended protection for twenty years under the TRIPs Agreement.

This book features 15 country reports on the patent enforcement practice of the world's most litigated countries in Europe, Asia and the Americas.

A brilliantly clear and up-to-date patent guidePatent law is changing, and this bestselling primer on patent law has up-to-date information on the America Invents Act, the most important change to American patent law in two centuries.

Das anlässlich des 50-jährigen Bestehens der VG WORT herausgegebene Werk beschreibt die Vorgeschichte und Geschichte der bekannten Autoren- und Verlegervereinigung auf der Grundlage einer breiten archivalischen Überlieferung.

There has been much written on the impact of international treaties like the Trade Related Aspects on Intellectual Property (TRIPS), which laments the failure of patent systems to respond to the interests of a diverse set of non-profit, public interest, and non-corporate entities.

This book analyses 4 central pieces of EU pharmaceutical regulation: the Orphan Drugs Regulation, the Paediatric Regulation, the Supplementary Protection Certificate Regulation, and the ATMP (Advanced Therapy Medicinal Products) Regulation.

An international consensus approach to patent remedies treating complex products such as smartphones, computer networks, and the Internet of Things.